Johanne I Weberpals Selected Research

Johanne I Weberpals Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 07/2008
10	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 08/2011
7	Carcinoma (Carcinomatosis) 10/2021 - 10/2017
3	Disease Progression 01/2021 - 01/2020
2	Diarrhea 01/2020 - 12/2018
2	Ovarian Epithelial Carcinoma 05/2015 - 07/2008
2	Squamous Cell Carcinoma of Head and Neck 11/2014 - 08/2012
1	Neutropenia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Anemia 01/2020
1	Vomiting 01/2020
1	Proteinuria 12/2018
1	Hypertension (High Blood Pressure) 12/2018
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2017
1	Vesicular Stomatitis 08/2012
1	Breast Neoplasms (Breast Cancer) 08/2011

Drug/Important Bio-Agent (IBA)

11	PlatinumIBA 12/2021 - 08/2011
6	rucaparibIBA 10/2021 - 10/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2011
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 10/2011
3	Proteins (Proteins, Gene)FDA Link 05/2015 - 07/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2011
2	adavosertibIBA 01/2021 - 01/2020
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2020 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 08/2017 - 01/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2016 - 11/2014
2	Cisplatin (Platino)FDA LinkGeneric 08/2011 - 01/2010
2	BRCA1 ProteinIBA 08/2011 - 07/2008
1	olaparibIBA 12/2021
1	Etoposide (VP 16)FDA LinkGeneric 12/2021
1	B7-H1 AntigenIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	chemotactic factor inactivatorIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	ENMD 2076IBA 12/2018
1	AntigensIBA 10/2017
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 08/2017
1	Rosuvastatin Calcium (Crestor)FDA Link 03/2016
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2015
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 05/2015
1	Monensin (Coban)IBA 11/2014
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 11/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2014
1	InterferonsIBA 08/2012
1	Histone Deacetylase InhibitorsIBA 08/2011
1	Messenger RNA (mRNA)IBA 08/2011
1	Vorinostat FDA Link 08/2011
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2008

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2021 - 08/2011
6	Therapeutics 01/2021 - 10/2011
1	Oncolytic Virotherapy 08/2012